Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
64.00    -2.30 (-3.47%)
Bid:
63.80
Ask:
64.40
Spread: 0.60 (0.94%)
Market Cap: £110.02m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Second Capital Distribution Update

18 Nov 2024 07:00

RNS Number : 5837M
GCP Asset Backed Income Fund Ltd
18 November 2024
 

GCP Asset Backed Income Fund Limited

("GABI" or the "Company")

LEI: 213800FBBZCQMP73A815

Second Capital Distribution Update

18 November 2024

The Board announces that in connection with the initial capital distribution announced on 6 November 2024, the Company has compulsory redeemed as at close of business on 15 November 2024 (the "Redemption Date") on a pro rate basis 50,409,977 ordinary shares at a price of 89.33875 pence per share, which was approximately 18.95% of the Company's ordinary shares in issue.

Fractions of ordinary shares produced by the applicable redemption ratio have not been redeemed and therefore the number of shares redeemed in respect of each shareholder has been rounded down to the nearest whole number of shares.

Payments of redemption monies are expected to be effected either through CREST (in the case of ordinary shares held in uncertificated form) or by cheque (in the case of ordinary shares held in certificated form) by 29 November 2024. Any certificates currently in circulation will be superseded by a new certificate which will be distributed to certificated shareholders by 29 November 2024.

Following the redemption, the Company has 215,606,413 ordinary shares in issue. Therefore, the total number of voting rights is 215,606,413 and may be used by shareholders as the denominator for determining if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

The new ISIN, JE00BSY6HT75 (the "New ISIN"), in respect of the remaining shares which have not been redeemed, has been enabled and is available for transactions from 8.00 a.m. on 18 November 2024. CREST will automatically transform any open transactions as at the Redemption Date into the New ISIN.

For further information, please contact:

GCP Asset Backed Income Fund Limited

Alex Ohlsson, Chairman

+44 (0)15 3482 2251

Barclays Bank PLC

Dion Di Miceli

Stuart Muress

James Atkinson

 

+44 (0)20 7623 2323

Gravis Capital Management Limited

Philip Kent

Anthony Curl

Cameron Gardener

+44 (0)20 3405 8500

Burson Buchanan

Helen Tarbet

Henry Wilson

Samuel Adams

 

+44 (0)20 7466 5000

Notes to the Editor

About GABI

GCP Asset Backed Income Fund Limited is a closed ended investment company. Its shares are traded on the Main Market of the London Stock Exchange. Its investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company's portfolio in an orderly manner.

The Company's portfolio comprises a diversified portfolio of predominantly UK based asset backed loans which are secured against contracted, predictable medium to long term cash flows and/or physical assets.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKDLFFZFLFFBV
Date   Source Headline
10th Sep 20207:00 amRNSHalf-Yearly Report & Financial Statements
31st Jul 20207:00 amRNSInvestor Report as at 30 June 2020
23rd Jul 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
15th Jul 20204:42 pmRNSSecond Price Monitoring Extn
15th Jul 20204:38 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSNet Asset Value and Investment Update
10th Jul 20207:00 amRNSExtension to term of Revolving Credit Facility
7th Jul 20204:22 pmRNSResult of AGM & EGM
17th Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
26th May 20207:00 amRNSTransaction in Own Shares
22nd May 20207:00 amRNSTransaction in Own Shares
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:37 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSNotices of AGM & EGM
4th May 20207:00 amRNSInvestor Report as at 31 March 2020
29th Apr 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
21st Apr 20207:00 amRNSNet Asset Value and Investment Update
7th Apr 20207:00 amRNSAnnual Report & AGM
31st Mar 20207:00 amRNSTotal Voting Rights
25th Mar 20207:00 amRNSTransaction in Own Shares
24th Mar 20207:00 amRNSTransaction in Own Shares
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSAnnual Report & Financial Statements
19th Mar 20207:00 amRNSTransaction in Own Shares
18th Mar 20207:00 amRNSCompliance with Market Abuse Regulation
28th Feb 20209:47 amRNSTotal Voting Rights & Additional Listing
21st Feb 20207:00 amRNSAdditional Listing
17th Feb 20207:00 amRNSInvestment in co-living
6th Feb 20207:00 amRNSScrip Share Reference Price
30th Jan 20207:00 amRNSInvestor report as at 31 December 2019
29th Jan 20207:00 amRNSChange of corporate adviser
22nd Jan 20207:00 amRNSDividend Declaration & Scrip Dividend Alternative
16th Jan 20207:00 amRNSNet Asset Value
16th Jan 20207:00 amRNSRevolving Credit Facility
29th Nov 20199:34 amRNSTotal Voting Rights and Additional Listing
25th Nov 20197:00 amRNSAdditional Listing
7th Nov 201910:08 amRNSScrip Share Reference Price
7th Nov 20197:00 amRNSDirectorate Change
31st Oct 20197:00 amRNSInvestor Report as at 30 September 2019
23rd Oct 20197:00 amRNSDividend Declaration & Scrip Dividend Alternative
23rd Oct 20197:00 amRNSSpecial dividend declaration
15th Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:00 amRNSTotal Voting Rights
10th Sep 20197:00 amRNSHalf-Yearly Report & Financial Statements
2nd Sep 201910:01 amRNSTotal Voting Rights & Additional Listing
22nd Aug 20197:00 amRNSAdditional Listing
8th Aug 20197:00 amRNSScrip Share Reference Price
2nd Aug 20197:00 amRNSInvestor Report as at 30 June 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.